abstract |
Disclosed is a pharmaceutical composition that includes a 5-alpha reductase inhibitor, can release the 5-alpha reductase inhibitor continuously, has reduced irritation, and has improved safety. A pharmaceutical composition comprising a 5-alpha reductase inhibitor, which is capable of forming a liquid crystal when touched with an aqueous fluid. [Selection] Figure 2 |